Defining digital twins in drug discovery and development

This whitepaper dissects the journey of the term digital twins from its engineering origins to its current healthcare applications. It highlights how the complexity of biological systems challenges its definition and necessitates a nuanced understanding of its capabilities and limitations. By demystifying the term and distinguishing between accurate digital twin applications and broader computational models, we aim to clarify its role in advancing healthcare innovation and improving patient outcomes.